Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.

[1]  A. Marin-Lopez,et al.  Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus , 2013, PloS one.

[2]  J. Crafford,et al.  An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses. , 2012, Veterinary immunology and immunopathology.

[3]  B. Sewell,et al.  Structural Insight into African Horsesickness Virus Infection , 2012, Journal of Virology.

[4]  J. Anguita,et al.  Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus , 2012, PloS one.

[5]  W. van Wyngaardt,et al.  Virus-specific CD8⁺ T-cells detected in PBMC from horses vaccinated against African horse sickness virus. , 2012, Veterinary immunology and immunopathology.

[6]  A. Firth,et al.  Detection of a Fourth Orbivirus Non-Structural Protein , 2011, PloS one.

[7]  R. Chiam,et al.  A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model , 2011, PloS one.

[8]  I. Gardner,et al.  Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus. , 2009, Vaccine.

[9]  R. Chiam,et al.  Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA) , 2009, PloS one.

[10]  J. Anguita,et al.  Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor , 2009, PloS one.

[11]  D. D. du Plessis,et al.  Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries. , 2000, The Journal of general virology.

[12]  G. Viljoen,et al.  Immune responses in a horse inoculated with the VP2 gene of African horsesickness virus. , 1999, The Onderstepoort journal of veterinary research.

[13]  P. Roy,et al.  Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge. , 1996, The Journal of general virology.

[14]  J. Sánchez-Vizcaíno,et al.  Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7. , 1996, The Journal of general virology.

[15]  P. Roy,et al.  Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4. , 1996, Virology.

[16]  J. Casal,et al.  Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus. , 1995, Virology.

[17]  P. Roy,et al.  African horse sickness virus structure. , 1994, Comparative immunology, microbiology and infectious diseases.

[18]  T. Burrage,et al.  Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2. , 1993, Virology.

[19]  L. Nel,et al.  A comparison of the nucleotide sequences of cognate NS2 genes of three different orbiviruses. , 1991, Virology.

[20]  N. Blackburn,et al.  Observations on antibody levels associated with active and passive immunity to African horse sickness , 1988, Tropical Animal Health and Production.

[21]  J. Parker.  African horse sickness , 1976, Veterinary Record.

[22]  Y. Ozawa,et al.  African horse-sickness killed-virus tissue culture vaccine. , 1966, Canadian journal of comparative medicine and veterinary science.

[23]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[24]  L. H..  Recombinant baculovirus-synthesized African horsesickness virus ( AHSV ) outer-capsid protein VP 2 provides protection against virulent AHSV challenge , 2007 .

[25]  P. Mellor,et al.  African Horse Sickness , 2022, Springer Vienna.

[26]  C. Mebus,et al.  Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine. , 1994, Vaccine.